Clinical trial
Integrating Buprenorphine Into the SFGH AIDS Program
NCT00263458 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00263458 |
|---|---|
| Title | Integrating Buprenorphine Into the SFGH AIDS Program |
| Official title | Integrating Buprenorphine Into the SFGH AIDS Program (Patient Evaluation Study) |
| Acronym | BHIVES-SF |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | San Francisco Department of Public Health The New York Academy of Medicine Health Resources and Services Administration (HRSA) U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV, Buprenorphine, Opioid Dependence |
| Intervention type | Other |
| Interventions | Integrated office-based buprenorphine treatment for opioid dependence in an HIV primary care setting |
| Enrollment | 37 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 8, 2005 |
| Last update posted | Sep 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: